Are Breast Cancer Subtypes Prognostic for Nodal Involvement and Associated with Clinicopathologic Features at Presentation in Early-Stage Breast Cancer?

被引:44
|
作者
Jones, Tiffanie [1 ]
Neboori, Hanmanth [2 ]
Wu, H. [2 ]
Yang, Qifeng [3 ]
Haffty, Bruce G. [2 ]
Evans, Susan [1 ]
Higgins, Susan [1 ]
Moran, Meena S. [1 ]
机构
[1] Yale Univ, Sch Med, New Haven, CT 06520 USA
[2] UMDNJ Robert Wood Johnson Sch Med, New Brunswick, NJ USA
[3] Shangdong Univ, Jinan, Peoples R China
关键词
TRIPLE-NEGATIVE PHENOTYPE; BASAL-LIKE SUBTYPE; MOLECULAR SUBTYPE; CONSERVATION THERAPY; AXILLARY DISSECTION; HORMONE-RECEPTOR; SURVIVAL; OUTCOMES; BIOPSY; WOMEN;
D O I
10.1245/s10434-013-2994-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer subtypes (BCS) determined from immunohistochemical staining have been correlated with molecular subtypes and associated with prognosis and outcomes, but there are limited data correlating these BCS and axillary node involvement. This study was conducted to assess whether BCS predicted for nodal metastasis or was associated with other clinicopathologic features at presentation. Patients with stage I/II disease who underwent breast-conserving surgery and axillary surgical assessment with available tissue blocks underwent a institutional pathological review and construction of a tissue microarray. The slides were stained for estrogen receptor, progesterone receptor, and HER-2/neu (HER-2) for classification into BCS. Nodal involvement and other clinicopathologic features were analyzed to assess associations between BCS and patient and tumor characteristics. Outcomes were calculated a function of BCS. The study cohort consisted of 453 patients (luminal A 48.6 %, luminal B 16.1 %, HER-2 11.0 %, triple negative 24.2 %), of which 22 % (n = 113) were node positive. There were no significant associations with BCS and pN stage, node positivity, or absolute number of nodes involved (p > 0.05 for all). However, there were significant associations with subtype and age at presentation (p < 0.001), method of detection (p = 0.049), tumor histology (p < 0.001), race (p = 0.041), and tumor size (pT stage, p < 0.001) by univariate and multivariate analysis. As expected, 10-year outcomes differed by BCS, with triple negative and HER-2 subtypes having the worse overall (p = 0.03), disease-free (p = 0.03), and distant metastasis-free survival (p < 0.01). There is a significant association between BCS and age, T stage, histology, method of detection, and race, but no associations to predict nodal involvement. If additionally validated, these findings suggest that BCS may not be a useful prognostic variable for influencing regional management considerations.
引用
收藏
页码:2866 / 2872
页数:7
相关论文
共 50 条
  • [21] The prognostic value of node status in different breast cancer subtypes
    Yang, Zheng-Jun
    Yu, Yue
    Hou, Xin-Wei
    Chi, Jiang-Rui
    Ge, Jie
    Wang, Xin
    Cao, Xu-Chen
    ONCOTARGET, 2017, 8 (03) : 4563 - 4571
  • [22] Update on the management of early-stage breast cancer
    Heilat, Ghaith Bahjat
    Brennan, Meagan E.
    French, James
    AUSTRALIAN JOURNAL OF GENERAL PRACTICE, 2019, 48 (09) : 604 - 608
  • [23] Improving Outcomes in Early-Stage Breast Cancer
    Glueck, Stefan
    Mamounas, Terry
    Klem, Jennifer
    ONCOLOGY-NEW YORK, 2010, 24 (11): : 5 - 15
  • [24] Adjuvant bisphosphonates for early-stage breast cancer
    Brufsky, Adam
    LANCET ONCOLOGY, 2011, 12 (07) : 610 - 611
  • [25] Alexithymia May Be Associated With Depression in Early-Stage Breast Cancer Patients
    Eraslan, Pinar
    Ilhan, Aysegul
    Karacin, Cengiz
    Oksuzoglu, Omur Berna Cakmak
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (09)
  • [26] Prognostic value of isolated tumour cells in sentinel lymph nodes in early-stage breast cancer: a prospective study
    Liikanen, Jenni S.
    Leidenius, Marjut H.
    Joensuu, Heikki
    Vironen, Jaana H.
    Meretoja, Tuomo J.
    BRITISH JOURNAL OF CANCER, 2018, 118 (11) : 1529 - 1535
  • [27] Survival following radiotherapy in young women with localized early-stage breast cancer according to molecular subtypes
    Liu, Qi-Qi
    Sun, He-Fen
    Yang, Xue-Li
    Chen, Meng-Ting
    Liu, Yang
    Zhao, Yang
    Zhao, Yuan-Yuan
    Jin, Wei
    CANCER MEDICINE, 2019, 8 (06): : 2840 - 2857
  • [28] Overview of Breast Cancer and Implications of Overtreatment of Early-Stage Breast Cancer: An Indian Perspective
    Bhattacharyya, Gouri Shankar
    Doval, Dinesh C.
    Desai, Chirag J.
    Chaturvedi, Harit
    Sharma, Sanjay
    Somashekhar, S. P.
    JCO GLOBAL ONCOLOGY, 2020, 6 : 789 - 798
  • [29] Trends and efficacy of omitting axillary lymph node dissection in early-stage male breast cancer with limited nodal involvement: A population-based cohort study
    Yang, Hanzhao
    Ruan, Yuxia
    Wang, Jiabin
    Qiao, Jianghua
    Liu, Zhenzhen
    CANCER MEDICINE, 2024, 13 (19):
  • [30] Annual surveillance mammography after early-stage breast cancer and breast cancer mortality
    Paszat, L. F.
    Sutradhar, R.
    Gu, S.
    Rakovitch, E.
    CURRENT ONCOLOGY, 2016, 23 (06) : E538 - E545